HALO logo
halo search icon
PTC Therapeutics, Inc.

US$71.02

Price Change Indicator
0.71 (1.01%)
PTC Therapeutics, Inc.
PTCT · NAS

PTC Therapeutics, Inc.

Start Trading PTCT for Free

US$71.02

Price Arrow0.71 (1.01%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Balance SheetHALO Earnings MomentumHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PTC Therapeutics, Inc. Overview

PTCT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Strong

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About PTCT

icon
icon

Telephone

1.908.222.7000

icon

Address

500 Warren Corporate Center Drive, Warren, NJ 07059

Description

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

PTCT Price Chart

Key Stats

Market Cap

US$5.83B

PE

9.80

EV/EBITDA

5.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 43.17 - 87.5

Trade Value (12mth)

US$21,349,757.00

1 week

-1.62%

1 month

-0.45%

YTD

-8.38%

1 year

52.15%

All time high

87.50

Key Fundamentals

EPS 3 yr Growth

-210.10%

EBITDA Margin

51.70%

Operating Cashflow

$711m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

5.90

Quick Ratio

2.30

Other Data

Shares Outstanding (Fully Diluted)

83m

HALO Sector

Healthcare

Next Company Report Date

23-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PTCT Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
29 April 26

PTCT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-8.37-4.738.58locklocklock
EPS (Fully Diluted)
 $locklocklocklock-8.37-4.737.78locklocklock
Growth
 %locklocklocklock-7.443.5281.6locklocklock
PE
 XlocklocklocklockN/AN/A9.8locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A5.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of PTC Therapeutics, Inc. (PTCT:NAS)?
Halo FAQ
The current share price of PTC Therapeutics, Inc. (PTCT:NAS) is USD$71.02.
What is the 52-week high share price for PTC Therapeutics, Inc. (PTCT:NAS)?
Halo FAQ
The 52-week high share price for PTC Therapeutics, Inc. (PTCT:NAS) is USD$87.50.
What is the 52-week low share price for PTC Therapeutics, Inc. (PTCT:NAS)?
Halo FAQ
The 52-week low share price for PTC Therapeutics, Inc. (PTCT:NAS) is USD$43.17.
What is the dividend yield for PTC Therapeutics, Inc. (PTCT:NAS)?
Halo FAQ
PTC Therapeutics, Inc. (PTCT:NAS) does not pay a dividend.
What was PTC Therapeutics, Inc. (PTCT:NAS) last dividend payment?
Halo FAQ
PTC Therapeutics, Inc. (PTCT:NAS) does not pay a dividend.
What is the franking level for PTC Therapeutics, Inc. (PTCT:NAS)?
Halo FAQ
PTC Therapeutics, Inc. (PTCT:NAS) has a franking level of 0.00%.
In which sector is PTC Therapeutics, Inc. (PTCT:NAS) classified?
Halo FAQ
PTC Therapeutics, Inc. (PTCT:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for PTC Therapeutics, Inc. (PTCT:NAS)?
Halo FAQ
The current P/E ratio for PTC Therapeutics, Inc. (PTCT:NAS) is 9.80.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial